Lv3
274 积分 2022-08-31 加入
Tumor Microenvironment-Responsive Antibody Fragment-Cleavable PEGylated Drug Conjugates (AFCDC) for Improved Tumor Penetration and Antitumor EfficacyClick to copy article link
1小时前
待确认
A Novel Dual-Payload ADC Platform Integrating Exatecan and Triptolide to Enhance Antitumor Efficacy and Overcome Resistance
3个月前
已完结
Extracellular targeted protein degradation: an emerging modality for drug discovery
3个月前
已完结
To degrade or not to degrade: mechanisms and significance of endocytic recycling
3个月前
已完结
Extracellular targeted protein degradation: an emerging modality for drug discovery
3个月前
已完结
To degrade or not to degrade: mechanisms and significance of endocytic recycling
3个月前
已完结
Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
4个月前
已完结
An array of 60,000 antibodies for proteome-scale antibody generation and target discovery
4个月前
已完结
Altering Antibody-Drug Conjugate Binding to the Neonatal Fc Receptor Impacts Efficacy and Tolerability
4个月前
已完结
Spatiotemporal Quantification of HER2-targeting Antibody–Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration
7个月前
已完结
皖公网安备34019202002308
